MedPath

Outcome of Radioiodine Treatment in Hyperthyroidism and Predictive Factors of Treatment Failure: A 10-Year Experience

Completed
Conditions
Hyperthyroidism Patient who was referred for I-131 treatment
Radioiodine treatment, I-131, Hyperthyroidism, Fixed dose
Registration Number
TCTR20220331001
Lead Sponsor
Prince of Songkla University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
1424
Inclusion Criteria

New case of hyperthyroidism who was referred for I-131 treatment

Exclusion Criteria

Patients who had a history of thyroid surgery, were aged < 18 years, or had undetermined results during the follow-up period at 6 months were excluded.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Success rate 6 months after I-131 treatment Thyroid function test
Secondary Outcome Measures
NameTimeMethod
Factors effecting treatment failure Since the beginning of the study, 6 months and 12 months after treatment review medical record all interesting factor
© Copyright 2025. All Rights Reserved by MedPath